XML 35 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Goodwill and Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of intangible assets by major asset class
The following sets forth the goodwill and intangible assets by major asset class:
 
 
 
 
March 31, 2017
 
December 31, 2016
 
Useful
Life
(Yrs)
Gross
 
Accumulated
Amortization
 
Net Book
Value
 
Gross
 
Accumulated
Amortization
 
Net Book
Value
Non-Amortizing:
 
 
 
 
 
 
 
 
 
 
 
 
 
Goodwill(a)
 
 
$
10,513,371

 
$
—

 
$
10,513,371

 
$
10,513,371

 
$
—

 
$
10,513,371

Amortizing:
 
 
 
 
 
 
 
 
 
 
 
 
 
Patents
8 – 17
 
5,802,528

 
(5,636,192
)
 
166,336

 
5,802,528

 
(5,618,854
)
 
183,674

Licenses
8 – 17
 
1,323,761

 
(1,169,048
)
 
154,713

 
1,323,761

 
(1,161,861
)
 
161,900

CELLECTRA®(b)
5 – 11
 
8,106,270

 
(6,931,798
)
 
1,174,472

 
8,106,270

 
(6,825,028
)
 
1,281,242

GHRH(b)
11
 
335,314

 
(248,185
)
 
87,129

 
335,314

 
(240,264
)
 
95,050

Bioject (c)
2 – 15
 
5,100,000

 
(773,055
)
 
4,326,945

 
5,100,000

 
(562,222
)
 
4,537,778

Other(d)
18
 
4,050,000

 
(2,737,500
)
 
1,312,500

 
4,050,000

 
(2,681,250
)
 
1,368,750

Total intangible assets
 
 
24,717,873

 
(17,495,778
)
 
7,222,095

 
24,717,873

 
(17,089,479
)
 
7,628,394

Total goodwill and intangible assets
 
 
$
35,231,244

 
$
(17,495,778
)
 
$
17,735,466

 
$
35,231,244

 
$
(17,089,479
)
 
$
18,141,765


(a)
Goodwill was recorded from the Inovio AS acquisition in January 2005, the acquisition of VGX in June 2009 and the acquisition of Bioject in April 2016 for $3.9 million, $6.2 million and $400,000, respectively.
(b)
CELLECTRA® and GHRH are developed technologies which were recorded from the acquisition of VGX.
(c)
Bioject intangible assets represent the fair value of developed technology and intellectual property which were recorded from the acquisition of Bioject.
(d)
Other intangible assets represent the fair value of acquired intellectual property from the Inovio AS acquisition.